纤维素原在耐性高血压患者的预后影响
Uğur Köktürk1, Hamdi Püşüroğlu2, İlyas Çetin2
1Department of Cardiology, Faculty of Medicine, Zonguldak Bülent Ecevit University, Zonguldak, Turkey. drugurkokturk@gmail.com.
Journal of human hypertension
|October 4, 2024
概括
高水平的纤维素素显著增加了抗性高血压患者的主要不良心血管事件 (MACE) 的风险. 降低纤维素因子可能会改善这些高风险个体的结果.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 生物标志物 生物标志物
背景情况:
- 抗性高血压带来了显著的心血管风险.
- 纤维素是凝血和炎症中的关键蛋白质.
- 纤维素原在耐性高血压中的预后价值需要进一步阐明.
研究的目的:
- 研究血清纤维素水平对抗性高血压患者主要心血管不良事件 (MACE) 的长期预后影响.
主要方法:
- 对266名耐性高血压患者进行了回顾性研究.
- 根据血清纤维素水平,患者分为三层.
- 5年随访评估MACE (所有原因死亡率,心血管死亡率,心肌梗塞,中风,心力衰竭,外周动脉疾病).
主要成果:
- 最高的纤维素三位数显示出MACE的发生率明显更高.
- 纤维素原是一种MACE的独立预测因子 (OR=1.002,p=0.009).
- MACE的风险在第2个三位数中是2.5倍高,在最高的三位数中是6.9倍高,与最低相比.
结论:
- 血清纤维素水平升高是抗性高血压中MACE的显著风险标志物.
- 纤维素水平可以预测MACE在这个患者群体.
- 针对纤维素原减少的治疗策略可能会改善心血管结果.
相关概念视频
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3


